Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A gained 1.070% today.
Our community is currently high on Bio-Rad Labs Inc. A with 5 Buy predictions and 0 Sell predictions.
With a target price of 334 € there is a hugely positive potential of 54.13% for Bio-Rad Labs Inc. A compared to the current price of 216.7 €.
Our community identified positive and negative aspects for Bio-Rad Labs Inc. A stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bio-Rad Labs Inc. A stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | 1.070% | -12.444% | -21.938% | -18.010% | -15.975% | -49.239% | -59.870% |
| Haemonetics Corp. | 2.470% | -12.072% | -25.496% | - | -28.759% | - | - |
| Merit Medical Systems | 0.740% | 2.239% | -2.143% | -32.843% | -7.432% | 6.202% | 38.664% |
| Bio-Techne Corp. | 0.990% | -8.182% | -16.529% | -21.094% | 1.000% | -29.371% | - |
Comments
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BIO provided by MarketBeat